• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
ATAGI issues advice on sedation for COVID-19 vaccination

ATAGI issues advice on sedation for COVID-19 vaccination

The advice, which is intended to be ‘general in nature’, was discussed at the advisory group’s most recent meeting.


TGA releases vaccine-related myocarditis severity details

TGA releases vaccine-related myocarditis severity details

Fewer than 1% of all likely myocarditis or pericarditis cases linked to mRNA vaccines in Australia have been treated in intensive care.


What impact are boosters having on illness and death in Australia?

What impact are boosters having on illness and death in Australia?

The distinct patterns of vaccination and infection across different states could already be giving a clear clue on booster efficacy.


Influenza ‘resurgence’ expected in coming months

Influenza ‘resurgence’ expected in coming months

Open borders and low immunity levels has added additional importance to year’s flu vaccine rollout, the Federal Health Secretary has written.


Extra booster dose recommended by ATAGI

Extra booster dose recommended by ATAGI

The rollout of additional COVID-19 vaccine doses for those ‘at greatest risk of severe illness’ will commence ahead of winter to tie in with flu vaccination.


How do we raise child COVID-19 vaccination rates?

How do we raise child COVID-19 vaccination rates?

With the dial barely moving on the proportion of younger children taking vaccines, experts are looking at what else can be done.


T cells provide long-lasting immunity against COVID: Study

T cells provide long-lasting immunity against COVID: Study

According to new Australian research, the T cell response to COVID-19 lasts for at least 15 months.


Booster take-up disparities widen

Booster take-up disparities widen

Striking contrasts in booster coverage are emerging in different local government areas. What can be done to address the inequities?


‘Surprising’ low antibody response in children with mild COVID

‘Surprising’ low antibody response in children with mild COVID

The research was conducted on adults and children with similar viral loads following infection with the Wuhan strain.


First safety data on Novavax released

First safety data on Novavax released

Early information on the administration of the Novavax vaccine in Australia is in line with clinical trials data, the TGA has reported.


  • Previous
  • ...
  • 10
  • 11
  • 12
  • ...
  • Next
Pages: 12 of 48
RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807